TAPTIMAT CT³N Pilot Grant	Print Issue
,

The CT3N (Center for Targeted Therapeutics and Translational Nanomedicine) invites Penn researchers from all Schools and partner institutions to submit competitive proposals for Pilot Grants by December 6, 2013. The goal of these Pilot Grants is to support early-stage experimental preclinical studies in targeted therapeutics and thus assist investigators in obtaining key data to seek extramural funding. The grants will be for up to $25,000 for one year, starting February 1, 2014. 

Please visit: www.itmat.upenn.edu/funding.shtml#CT3N

—Vladimir Muzykantov, Director